Results 181 to 190 of about 26,501 (228)

Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma. [PDF]

Front Oncol
Wu Y, Yu M, Zhou T, Tian Y, Song Y.
europepmc   +1 more source

The effect of prior transarterial chemoembolization on response to immune checkpoint inhibitor treatment in patients with hepatocellular carcinoma. [PDF]

Clin Mol Hepatol
Myojin Y, Schäffer AA, Ruppin E, Greten TF.   +3 more
europepmc   +1 more source

Characterization of hepatocellular carcinoma patient-derived organoids from patients receiving transarterial chemoembolization as a model for preclinical drug response assessment. [PDF]

Sci Rep
Khaled J, Nyman SS, Dahlgren D, Rorsman F, Lennernäs H, Barbier CE, Heindryckx F.   +6 more
europepmc   +1 more source

Transarterial Chemoembolization Combined With Lenvatinib in the Treatment of Intermediate-Stage Hepatocellular Carcinoma With Hypovascular Nodules: A Retrospective Cohort Study. [PDF]

Clin Med Insights Oncol
Yang J, Shi F, Jiang N, Zhang S, Yin Y, Yu B, Feng W, Chu H, Ni C.   +8 more
europepmc   +1 more source

Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study. [PDF]

Liver Cancer
Jiang N, Zhang W, Peng Z, Liu C, Xiao YD, Yang WZ, Ding R, Yin LN, Jiang JQ, Ni CF, Yan ZP, Kuang M, Teng GJ, Zhong BY.   +13 more
europepmc   +1 more source

Efficacy and safety of transarterial chemoembolization combined with donafenib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus: a dual-center, retrospective propensity score-matched analysis. [PDF]

Front Immunol
Zhang Q, Qing H, Lei Z, Xie X.
europepmc   +1 more source

Application of Preoperative Transarterial Chemoembolization Before Hilar Liver Tumour Resection in a Dog. [PDF]

Vet Med Sci
Son H, Jeon S, Kim J, Lee S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transarterial Chemoembolization and Radioembolization

Seminars in Liver Disease, 2014
Transarterial chemoembolization (TACE) and radioembolization (RE) are frequently used to treat patients with hepatocellular carcinoma who cannot receive curative therapies. Transarterial chemoembolization is a heterogeneous group of procedures; based on two positive clinical trials and three meta-analyses, conventional TACE is the standard of care for ...
Riad Salem, Bruno Sangro
exaly   +3 more sources

Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

Expert Review of Anticancer Therapy, 2014
Transarterial chemoembolization (TACE) is considered as the standard therapy for patients with intermediate-stage hepatocellular carcinoma. However, given the high heterogeneity of this population, no common strategy or protocol standardization has been defined yet. In the last few years TACE treatment has been combined with sorafenib systemic therapy,
Giuseppe, Cabibbo, Silvia, Tremosini, Giovanni, Galati, Giancarlo, Mazza, Gennaro, Gadaleta-Caldarola, Giuseppe, Lombardi, Michela, Antonucci, Rodolfo, Sacco   +7 more
openaire   +2 more sources

Transarterial chemoembolization for patients with hepatocellular carcinoma

Hepatology Research, 2007
Hepatocellular carcinoma (HCC) has gained interest among the scientific community due to its increasing incidence in developed countries and the improvement of its diagnostic algorithm and therapeutic approach. Despite the universal implementation of screening programs in cirrhotics through biannual abdominal ultrasound, only 30% of HCC are diagnosed ...
Alejandro, Forner, M Isabel, Real, Maria, Varela, Jordi, Bruix   +3 more
openaire   +2 more sources